Washington University School of Medicine, Barnes-Jewish Hospital, Campus Box 8234, 660 South Euclid Avenue, Saint Louis, MO 63110-1093, USA.
Washington University School of Medicine, Barnes-Jewish Hospital, Campus Box 8234, 660 South Euclid Avenue, Saint Louis, MO 63110-1093, USA.
Thorac Surg Clin. 2021 May;31(2):221-227. doi: 10.1016/j.thorsurg.2021.02.003.
Although there are multiple pharmacologic and nonpharmacological options to alleviate symptoms of emphysema, none of these treatment modalities halts disease progression. The expanding disease burden has led to development of innovative therapeutic strategies that also aim to induce lung volume reduction. Bronchoscopic lung volume reduction originated in 2001 and has continued to grow rapidly ever since. This article discusses more recent developments in bronchoscopic and novel interventions and speculates on how these novel strategies may impact the future of lung reduction interventions.
尽管有多种药物和非药物选择可以缓解肺气肿的症状，但这些治疗方法都不能阻止疾病的进展。不断扩大的疾病负担导致了创新治疗策略的发展，这些策略也旨在诱导肺容积减少。支气管镜肺减容术始于 2001 年，自此以来一直在迅速发展。本文讨论了支气管镜和新型干预措施的最新进展，并推测这些新策略可能如何影响肺减容干预的未来。
